{"ticker": {"uuid": "0b72054a-3902-4a90-bc7f-0dbfc04b2618", "symbol": "SUPN", "name": "Supernus Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Supernus Celebrates Five-Year Anniversary of Qelbree\u00ae FDA Approval, Continuing to Deliver on Real-World Experience in ADHD", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/supernus-celebrates-five-anniversary-qelbree-123000281.html", "source_name": "GlobeNewswire", "published_at": "2026-07-14T12:30:00+00:00", "published_display": "14 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strength Seen in Supernus (SUPN): Can Its 5.2% Jump Turn into More Strength?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQbl92RkREWUdlS0hBTVNjNlJ5Z1VxVldFRFVUaENLSF83czdqZF9UdFV1Uzh6Tk1qbW5qcDRRblEzQWYxODhCWnYyMFdLQ2tpQXVqdmxtR1N6Ym9oaGRRMTRiaGFVbS1HWHYzWEpnblBGQm50ZDFZM2Y5NEQwd2dPTHRBYk9LelNzcDVQalVBOWJXODhIeWl0c1dR?oc=5", "source_name": "Market source", "published_at": "2026-07-09T13:25:00+00:00", "published_display": "09 Jul 2026 13:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Supernus Pharmaceuticals, Inc. \u2013 NASDAQ:SUPN", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQRFl2LWRJYTcwcTl0Smh3N0VJMk5iTXZEb0JDcFVueS1BSjI1R05XVWNoSTNYdFlJQlhWc2FOU2RJZURBLWRiQXZncUIwVEZYOFBuUTRZQVZvYnVYQWI5S0sxcEZsUVUtTU9xeDhCWjNVT3RJekhsYmlBblkxX2h1ZkhELTRfd2RoQ0Q4T01BemJwNm13VzEzR2s3NDg4NUl1cWFIc0NyeGdHNWk5ZFE?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T16:05:40+00:00", "published_display": "07 Jul 2026 16:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharmaceuticals (SUPN) Following Shelf Filing Has Its Undervalued Case In Focus", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Branded Pharmaceuticals Stocks Q1 Teardown: Supernus Pharmaceuticals (NASDAQ:SUPN) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNdlhna2t4RDFoMHMwcnh4R0ZkWjdSU0lRNkZ5c2VfOGxHblEyTUU3SnZpWmZpSDVKZU5MTjgxSDB2dXJwMzlKMFUtNEwtdDZmWk5TNkc2Rk96THJYMjhUNVJ2VDRMT240SUF5TDVpeFdsWldWUEZqQVMzY1pBLVhyTUxCMFBBMV9BTGppMkYybVBYNnRBZGVDbkZhT3pLNTBSaG9naFp3?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Strong Quarterly Results and MERGE Partnership Will Impact Supernus Pharmaceuticals (SUPN) Investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Expands Partnership With MERGE as AI-Powered Agency of Record", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/supernus-expands-partnership-merge-ai-141500222.html", "source_name": "GlobeNewswire", "published_at": "2026-06-17T14:15:00+00:00", "published_display": "17 Jun 2026 14:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus CVR Milestone Triggers Cash Outflow And Undervalued Stock Debate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQZGZuTXlrOEJ3RVZPYVJRc0hITFNLNDE0eVJFeGNRQndUbkgwdGdUYnVhMXVESVFmRmJBTlJ5cmt6TlNfZXdlZTlya1BUY3dtYU5fenJ2eXVFcXFKUDRUcHNxYTBubDl5QkNacFVrZ1NWTU9PTVJkSXhEeVQ5WFdDWWJNc3g1a09QcEdYN294WW1XWDg5WGhHS2E3MGplRDBQQkYw?oc=5", "source_name": "Market source", "published_at": "2026-05-24T07:00:00+00:00", "published_display": "24 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Q1 2026 Earnings Beat Reshape the Bull Case for Supernus Pharmaceuticals (SUPN)?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQNF9sRks3UllieFBVWUpzTFRpajh6ZU5jV0FfWDQyUXVLRU5ua3MtQnNoT0pYWUFnTzdXRVpsenhrSndwLWpOOHpVUDR5UWJCT0otUjl4UWpNNEUyd1lucE5QUm1tQ1VzQXJzSjRYb1h1bXBFVnJkSy15OFpCaFBDMjFqWWhHQkF5cTBNeHNCTWRyTDZGM3c?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVWllU1pfejY1ME96M25vZmt6VktWQkhuakZNUVRtZG9RZGpTSVhVaTZmU0ZpUWo3bmU3YW1zQzR3ZlBhRVRTMno2cVNjTHdJZUhFZTNBMnY0cUVQenphUGpfZG9YSlJFUlczUUVhV29IYWNLQ3hwU1FjaTZYUXIyRGV4aGJQLXNJSFd5Ym5jZDJfcDhXVWozS0pGZG5PZGQ3bUlNdHhrcElrXzBaWVhrWEtwRWhxM3BOMmc?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOQzFmMFNfbUpIbnBmSGRoY3RKYlBFY3FnaXZVNVVncjhNU1dsbFpZMGNuTmFQSTdwa3BBT1RwUDdQbzRXNEVPSks2TDBMZERpRnZKNUNETjVlMk5uaWxnSEU3RmR1T2JKNEpXSmZQNVZNM3U1UG9HX2p1STJmY1VSWEZfY3lseFdHMFZKX0g4NWFpMjVSbkZGUGlKQXBWUFZ6ZXotVlRfdTJSenpNRTlReHdfOHpKZw?oc=5", "source_name": "StockStory", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharmaceuticals (SUPN) Beats Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYnBjdUdOUGlVcXR5dy1IX2FKWVhnYlZXUzlNTWpkeTVYWm9Lazh6MnNjeGlMYVlQbG9DZ2pBVWtTT1VnZG5xRXFSa3NIOWVlVl90b2J6QTRkZ3pRTkRHN283cmxNLWVYNmtPY0pTZEpidUxhS05LQk5wTnl3UUstM0lHNENXX1VNaVBkUmlkUG96VDkxUGotcENnODRRSzBnb05tN1ZaN0U2Z0k?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Announces First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPYWdrVFZxSHBfcWFSbjNzWkI1MHNpeHF1UUdDT0JSV0RhNFhsNkRWbjlIWXNhV2prSm5QOV9rd1V2bGc5MllkcERQN0s4N0hHVEFIZmZ2cDlkMEhqeXltQnFGNzRpWEdQeHd6S3A1b19xOGJieUtfOFhwZ1Y2ZFZWTzlvWUdMd1BpQXR0SXp1OWViLUpKN1Y1UWR2ay1nU0djSTN6dWpqVERaODNGYlVoVzZPbndOVHZrRmFabUhOdkhNYkt5c0lRUA?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SUPERNUS PHARMACEUTICALS ($SUPN) Releases Q1 2026 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQSTNWOW9FOUZzZlpwVU1TSXh4TmhBQm1KZTRiendUNWRuU2dHbjlIc3hWQ05qb2p6YmN4SFNuRWhJY1ZZYmhRV3M5RXdHZWdFRUxKc3BaWDk2R2g2Q0pJRXoxZ0FqQWdaQkNKb05SUVpvZHdHLXFIeVdFS0RxbEFTZTZHVGE0bmlVa09qLTUzYjYzRVBGekpsMHItVUxBa1R2bXcxdEpJOA?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Branded Pharmaceuticals Stocks Q4 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNOEFZcnVjdjIxbWF2cWpQcjdaNWxqUFBJS2k4WFhkd2tucVBrUFFZRDhwTFlicVgzRnViZkxNME5FemxVbzlNWElGVmQwQmtXVzUxRXRsOTRjUjBsVWJGUTI0YW5KRWFCbi1mS25QckN0cmdfdDVFLUEyZlNFdjgtaFNyVS1rSGs0NlRNN0U2LTd5OGJ3Mk8ybjJTSGQtRXNVQlN1bzYwMkhHRlVpbnd3?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQVWh1LXZQejkySmpfbmdEcEVkQm9YQUxRTjhXUXlBVEU4dWl0VUh0cVNCc0VoX25LYUNXVXlPdDl0TUNsX0dISzh0bjJEQlR4bDRaTE8tN0VkdGNGQWZURWUtdllpZUc5a25vUVFTN1djTkdDWEhyYThPanJpOFItVHFxck80WEFHT2pYY19pMmNTTUJSSUpFRXVaeXRhYTBNcGF5VGZ1MzRqUWlVSTlCM29hV0lvSG8xTHVQWVVacWo?oc=5", "source_name": "The Motley Fool", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Supernus Pharmaceuticals (SUPN) After A 74% One-Year Surge?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Supernus Pharmaceuticals (SUPN) Valuation After Recent Share Price Momentum And Pipeline Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOZW42MFJKX25JS0k3T0tuM3oxVW1sZ0p0cXA3eXcyN1J6c3NPY0I3LVFiNGFNbkY1VkhLRU1kc3JkTVk0b1d1a1RERFRMVjNHSTIycWlKVWNyTC0wN1dCMFNzWm9EWGsxMFRQLVNVbWpja05xeC05NXgtYVFTbG5QZENsU1hWM3V2X0hXYkJ2MzNfdjNUN0I0TWhFMA?oc=5", "source_name": "Market source", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOakoycDIwTUtpUTlFYkEzMk53dEd5VVpFdUZOZ3VOM3BTbkVwTWdiWi12U1ZUZ0pfcUZ3RVVkR3d1VjdqOTF2QWxOb1lLS0hEaHZabzBZMWtjZk5UV1hWcWQ2TDF3NmtfYlY4R0tkS092bEF1Q1Y4NDZsMm44MUFaVERodkNiOVotcHA3Wk9ReG1zY3owYlN2UWdtMnRISUViMFFaeURLdXhQNXFCLVFaOXphYmJhMWltdlR3Zi1MN213RDRaSG8wbUNWbUYwWjhsdWhOUEpZR0Y5VFU?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-07-31T07:00:00+00:00", "published_display": "31 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus enters depression drug market with up to $795 million Sage deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNamdHb2Fna0czcW5JOWhuTThPaGZEb256dmI1a24ycXY3MnN2MGoyVk5zeGVKQXZqRjZDclRCazNQeUptZThsZV9mMVVVY25vOVppRnpSa0V5b2MxNHlscFhsU0JraFNaWEE4Y3hsQkxUbmdzRG5iT0lvM2lXYTV0Y2x1TFhKeGxab0NKajAxZ0pfWi1BNnhiVGdlX01MTzlXOWNpeFpmbEhmSnNrcHRheUxFZHhEbUVEQ0NZaUNrOFo1emtHRDg4TzdVdEp4UQ?oc=5", "source_name": "Reuters", "published_at": "2025-06-16T07:00:00+00:00", "published_display": "16 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgJBVV95cUxOWmxxTE15UmE3alNkMVotWEV6OHlGdnlocmVDYUoxUGVzVHJIdjVZeXN2TFVrQlhsdzN5M2I5Wlo1LTFXSThXdzRKbUJ2M3ZtOTFTZEdYdzljTGprN1VxVUFwakZyQTN4N1kzOTIwTW9aMGtfNEpHQmZjT1Z3ZGRycWtCSUp2Z2toc2gzOHBGeDNYSEFMdW5TdUI1WEpnTEZJeFlLdXdZUU9TRTVPNGRSRWlJRkg5UFRNdUxJdHRYUDJjQkZ6aUZDblZJWmV2a0xHS2xyaGdZa1JXZlFyZkdmR182OEE0SVVjRVdnQXFJZ3JjUVBqcTkwdGdIYWNCZzFzdDFYMEFVcnIzQkt3aXc?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-06-16T07:00:00+00:00", "published_display": "16 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sage, following setbacks, to sell to Supernus for $561M", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQOVNqSlVFeFVxc0VQaVFoaG4ycXZpdVdNVmx4SVprZzZkZlNTd3VfYlFnQXZVUzREdTlWWUEySXlOT05aWHBPRklOVG4ycGZDS3JIYzJZU2RHc0NfaUdPM0E1Xzh3QkFENzhEeTBzNmZOeEc1QXd5WWIyS0JaQ0JZR2tVOE45ZGVYWVVmYkxFZTlCRFNzN2c0?oc=5", "source_name": "BioPharma Dive", "published_at": "2025-06-16T07:00:00+00:00", "published_display": "16 Jun 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Supernus Celebrates Five-Year Anniversary of Qelbree\u00ae FDA Approval, Continuing to Deliver on Real-World Experience in ADHD", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/supernus-celebrates-five-anniversary-qelbree-123000281.html", "source_name": "GlobeNewswire", "published_at": "2026-07-14T12:30:00+00:00", "published_display": "14 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strength Seen in Supernus (SUPN): Can Its 5.2% Jump Turn into More Strength?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQbl92RkREWUdlS0hBTVNjNlJ5Z1VxVldFRFVUaENLSF83czdqZF9UdFV1Uzh6Tk1qbW5qcDRRblEzQWYxODhCWnYyMFdLQ2tpQXVqdmxtR1N6Ym9oaGRRMTRiaGFVbS1HWHYzWEpnblBGQm50ZDFZM2Y5NEQwd2dPTHRBYk9LelNzcDVQalVBOWJXODhIeWl0c1dR?oc=5", "source_name": "Market source", "published_at": "2026-07-09T13:25:00+00:00", "published_display": "09 Jul 2026 13:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Supernus Pharmaceuticals, Inc. \u2013 NASDAQ:SUPN", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQRFl2LWRJYTcwcTl0Smh3N0VJMk5iTXZEb0JDcFVueS1BSjI1R05XVWNoSTNYdFlJQlhWc2FOU2RJZURBLWRiQXZncUIwVEZYOFBuUTRZQVZvYnVYQWI5S0sxcEZsUVUtTU9xeDhCWjNVT3RJekhsYmlBblkxX2h1ZkhELTRfd2RoQ0Q4T01BemJwNm13VzEzR2s3NDg4NUl1cWFIc0NyeGdHNWk5ZFE?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T16:05:40+00:00", "published_display": "07 Jul 2026 16:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharmaceuticals (SUPN) Following Shelf Filing Has Its Undervalued Case In Focus", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Branded Pharmaceuticals Stocks Q1 Teardown: Supernus Pharmaceuticals (NASDAQ:SUPN) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNdlhna2t4RDFoMHMwcnh4R0ZkWjdSU0lRNkZ5c2VfOGxHblEyTUU3SnZpWmZpSDVKZU5MTjgxSDB2dXJwMzlKMFUtNEwtdDZmWk5TNkc2Rk96THJYMjhUNVJ2VDRMT240SUF5TDVpeFdsWldWUEZqQVMzY1pBLVhyTUxCMFBBMV9BTGppMkYybVBYNnRBZGVDbkZhT3pLNTBSaG9naFp3?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Strong Quarterly Results and MERGE Partnership Will Impact Supernus Pharmaceuticals (SUPN) Investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Expands Partnership With MERGE as AI-Powered Agency of Record", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/supernus-expands-partnership-merge-ai-141500222.html", "source_name": "GlobeNewswire", "published_at": "2026-06-17T14:15:00+00:00", "published_display": "17 Jun 2026 14:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus CVR Milestone Triggers Cash Outflow And Undervalued Stock Debate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQZGZuTXlrOEJ3RVZPYVJRc0hITFNLNDE0eVJFeGNRQndUbkgwdGdUYnVhMXVESVFmRmJBTlJ5cmt6TlNfZXdlZTlya1BUY3dtYU5fenJ2eXVFcXFKUDRUcHNxYTBubDl5QkNacFVrZ1NWTU9PTVJkSXhEeVQ5WFdDWWJNc3g1a09QcEdYN294WW1XWDg5WGhHS2E3MGplRDBQQkYw?oc=5", "source_name": "Market source", "published_at": "2026-05-24T07:00:00+00:00", "published_display": "24 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Q1 2026 Earnings Beat Reshape the Bull Case for Supernus Pharmaceuticals (SUPN)?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQNF9sRks3UllieFBVWUpzTFRpajh6ZU5jV0FfWDQyUXVLRU5ua3MtQnNoT0pYWUFnTzdXRVpsenhrSndwLWpOOHpVUDR5UWJCT0otUjl4UWpNNEUyd1lucE5QUm1tQ1VzQXJzSjRYb1h1bXBFVnJkSy15OFpCaFBDMjFqWWhHQkF5cTBNeHNCTWRyTDZGM3c?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVWllU1pfejY1ME96M25vZmt6VktWQkhuakZNUVRtZG9RZGpTSVhVaTZmU0ZpUWo3bmU3YW1zQzR3ZlBhRVRTMno2cVNjTHdJZUhFZTNBMnY0cUVQenphUGpfZG9YSlJFUlczUUVhV29IYWNLQ3hwU1FjaTZYUXIyRGV4aGJQLXNJSFd5Ym5jZDJfcDhXVWozS0pGZG5PZGQ3bUlNdHhrcElrXzBaWVhrWEtwRWhxM3BOMmc?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOQzFmMFNfbUpIbnBmSGRoY3RKYlBFY3FnaXZVNVVncjhNU1dsbFpZMGNuTmFQSTdwa3BBT1RwUDdQbzRXNEVPSks2TDBMZERpRnZKNUNETjVlMk5uaWxnSEU3RmR1T2JKNEpXSmZQNVZNM3U1UG9HX2p1STJmY1VSWEZfY3lseFdHMFZKX0g4NWFpMjVSbkZGUGlKQXBWUFZ6ZXotVlRfdTJSenpNRTlReHdfOHpKZw?oc=5", "source_name": "StockStory", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharmaceuticals (SUPN) Beats Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYnBjdUdOUGlVcXR5dy1IX2FKWVhnYlZXUzlNTWpkeTVYWm9Lazh6MnNjeGlMYVlQbG9DZ2pBVWtTT1VnZG5xRXFSa3NIOWVlVl90b2J6QTRkZ3pRTkRHN283cmxNLWVYNmtPY0pTZEpidUxhS05LQk5wTnl3UUstM0lHNENXX1VNaVBkUmlkUG96VDkxUGotcENnODRRSzBnb05tN1ZaN0U2Z0k?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Announces First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPYWdrVFZxSHBfcWFSbjNzWkI1MHNpeHF1UUdDT0JSV0RhNFhsNkRWbjlIWXNhV2prSm5QOV9rd1V2bGc5MllkcERQN0s4N0hHVEFIZmZ2cDlkMEhqeXltQnFGNzRpWEdQeHd6S3A1b19xOGJieUtfOFhwZ1Y2ZFZWTzlvWUdMd1BpQXR0SXp1OWViLUpKN1Y1UWR2ay1nU0djSTN6dWpqVERaODNGYlVoVzZPbndOVHZrRmFabUhOdkhNYkt5c0lRUA?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SUPERNUS PHARMACEUTICALS ($SUPN) Releases Q1 2026 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQSTNWOW9FOUZzZlpwVU1TSXh4TmhBQm1KZTRiendUNWRuU2dHbjlIc3hWQ05qb2p6YmN4SFNuRWhJY1ZZYmhRV3M5RXdHZWdFRUxKc3BaWDk2R2g2Q0pJRXoxZ0FqQWdaQkNKb05SUVpvZHdHLXFIeVdFS0RxbEFTZTZHVGE0bmlVa09qLTUzYjYzRVBGekpsMHItVUxBa1R2bXcxdEpJOA?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Branded Pharmaceuticals Stocks Q4 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNOEFZcnVjdjIxbWF2cWpQcjdaNWxqUFBJS2k4WFhkd2tucVBrUFFZRDhwTFlicVgzRnViZkxNME5FemxVbzlNWElGVmQwQmtXVzUxRXRsOTRjUjBsVWJGUTI0YW5KRWFCbi1mS25QckN0cmdfdDVFLUEyZlNFdjgtaFNyVS1rSGs0NlRNN0U2LTd5OGJ3Mk8ybjJTSGQtRXNVQlN1bzYwMkhHRlVpbnd3?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQVWh1LXZQejkySmpfbmdEcEVkQm9YQUxRTjhXUXlBVEU4dWl0VUh0cVNCc0VoX25LYUNXVXlPdDl0TUNsX0dISzh0bjJEQlR4bDRaTE8tN0VkdGNGQWZURWUtdllpZUc5a25vUVFTN1djTkdDWEhyYThPanJpOFItVHFxck80WEFHT2pYY19pMmNTTUJSSUpFRXVaeXRhYTBNcGF5VGZ1MzRqUWlVSTlCM29hV0lvSG8xTHVQWVVacWo?oc=5", "source_name": "The Motley Fool", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Supernus Pharmaceuticals (SUPN) After A 74% One-Year Surge?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Supernus Pharmaceuticals (SUPN) Valuation After Recent Share Price Momentum And Pipeline Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOZW42MFJKX25JS0k3T0tuM3oxVW1sZ0p0cXA3eXcyN1J6c3NPY0I3LVFiNGFNbkY1VkhLRU1kc3JkTVk0b1d1a1RERFRMVjNHSTIycWlKVWNyTC0wN1dCMFNzWm9EWGsxMFRQLVNVbWpja05xeC05NXgtYVFTbG5QZENsU1hWM3V2X0hXYkJ2MzNfdjNUN0I0TWhFMA?oc=5", "source_name": "Market source", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOakoycDIwTUtpUTlFYkEzMk53dEd5VVpFdUZOZ3VOM3BTbkVwTWdiWi12U1ZUZ0pfcUZ3RVVkR3d1VjdqOTF2QWxOb1lLS0hEaHZabzBZMWtjZk5UV1hWcWQ2TDF3NmtfYlY4R0tkS092bEF1Q1Y4NDZsMm44MUFaVERodkNiOVotcHA3Wk9ReG1zY3owYlN2UWdtMnRISUViMFFaeURLdXhQNXFCLVFaOXphYmJhMWltdlR3Zi1MN213RDRaSG8wbUNWbUYwWjhsdWhOUEpZR0Y5VFU?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-07-31T07:00:00+00:00", "published_display": "31 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus enters depression drug market with up to $795 million Sage deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNamdHb2Fna0czcW5JOWhuTThPaGZEb256dmI1a24ycXY3MnN2MGoyVk5zeGVKQXZqRjZDclRCazNQeUptZThsZV9mMVVVY25vOVppRnpSa0V5b2MxNHlscFhsU0JraFNaWEE4Y3hsQkxUbmdzRG5iT0lvM2lXYTV0Y2x1TFhKeGxab0NKajAxZ0pfWi1BNnhiVGdlX01MTzlXOWNpeFpmbEhmSnNrcHRheUxFZHhEbUVEQ0NZaUNrOFo1emtHRDg4TzdVdEp4UQ?oc=5", "source_name": "Reuters", "published_at": "2025-06-16T07:00:00+00:00", "published_display": "16 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgJBVV95cUxOWmxxTE15UmE3alNkMVotWEV6OHlGdnlocmVDYUoxUGVzVHJIdjVZeXN2TFVrQlhsdzN5M2I5Wlo1LTFXSThXdzRKbUJ2M3ZtOTFTZEdYdzljTGprN1VxVUFwakZyQTN4N1kzOTIwTW9aMGtfNEpHQmZjT1Z3ZGRycWtCSUp2Z2toc2gzOHBGeDNYSEFMdW5TdUI1WEpnTEZJeFlLdXdZUU9TRTVPNGRSRWlJRkg5UFRNdUxJdHRYUDJjQkZ6aUZDblZJWmV2a0xHS2xyaGdZa1JXZlFyZkdmR182OEE0SVVjRVdnQXFJZ3JjUVBqcTkwdGdIYWNCZzFzdDFYMEFVcnIzQkt3aXc?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-06-16T07:00:00+00:00", "published_display": "16 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sage, following setbacks, to sell to Supernus for $561M", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQOVNqSlVFeFVxc0VQaVFoaG4ycXZpdVdNVmx4SVprZzZkZlNTd3VfYlFnQXZVUzREdTlWWUEySXlOT05aWHBPRklOVG4ycGZDS3JIYzJZU2RHc0NfaUdPM0E1Xzh3QkFENzhEeTBzNmZOeEc1QXd5WWIyS0JaQ0JZR2tVOE45ZGVYWVVmYkxFZTlCRFNzN2c0?oc=5", "source_name": "BioPharma Dive", "published_at": "2025-06-16T07:00:00+00:00", "published_display": "16 Jun 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 64, "total_relevant": 23, "sentiment_summary": {"positive": 6, "negative": 1, "neutral": 16, "score": 53, "total": 23, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 6.05, "count": 11}, {"event": "earnings", "label": "Earnings", "weight": 3.3, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 2.0, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 48.46, "latest_week": "2026-07-10", "one_week_move": 0.9, "four_week_move": 9.1, "twelve_week_move": -5.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.615881, "market_dynamics_buy_signal": false, "relative_strength": -12.648048, "fair_value_gap": 32.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 50.8282, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.9% over one week, +9.1% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 50, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 8}, {"label": "GlobeNewswire", "count": 5}, {"label": "simplywall.st", "count": 3}, {"label": "TradingView", "count": 1}, {"label": "Ad Hoc News", "count": 1}, {"label": "StockStory", "count": 1}, {"label": "Quiver Quantitative", "count": 1}, {"label": "The Motley Fool", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 23}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Earnings", "count": 6}, {"label": "Deals and strategy", "count": 3}, {"label": "Regulatory and legal", "count": 1}, {"label": "Balance sheet", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "23", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.9% over one week, +9.1% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Supernus Celebrates Five-Year Anniversary of Qelbree\u00ae FDA Approval, Continuing to Deliver on Real-World Experience in ADHD"}], "updated_at": "2026-07-16T10:52:57.649437+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}